Document is current
Any future updates will be listed below
-
Authors
Li, Shanshan https://orcid.org/0000-0003-2605-4309
Wang, Nanxi https://orcid.org/0000-0003-2807-1487
Yu, Bingchen
Sun, Wei https://orcid.org/0000-0001-9607-1361
Wang, Lei https://orcid.org/0000-0002-5859-2526
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM118384)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA258300)
- License Information
-
More Information
Article History
Received: 28 April 2021
Accepted: 2 September 2022
First Online: 10 October 2022
Competing interests
: L.W., S.L. and N.W. are inventors on a patent application filed as International Application No. PCT/US2022/031925 by The Regents of the University of California. The patent application covers the unnatural amino acid SFY and its ability to crosslink carbohydrates, as described in the article. The other authors (B.Y. and W.S.) declare no competing interests.
